# Nutex Health (NUTX) — Earnings

NUTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nutx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $9.38 |
| EPS estimate | $4.95 |
| EPS surprise | +89.34% |
| Revenue surprise | −1.99% |
| Revenue | $210.8M |
| Revenue estimate | $215.0M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1479681/000162828026054268/nutx-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/820ca55d-3773-6984-0a31-bd295ca2d526.html) |

Nutex Health reported Q2 2026 results on August 6, 2026. Earnings per share were $9.38, ahead of the $4.95 estimate by 89.34%. Revenue was $210.8 million, slightly below the $215.0 million consensus. Compared with Q2 2025, the result swung from a loss of $2.95 per share to a profit, while revenue fell about 14% from $244.0 million.

The record is short: 15 quarters from Q3 2022, with no row for Q3 2025. Early quarters were losses, including a loss of $94.50 per share in Q3 2022 and a full-year 2023 loss of $12.00 per share. Results then changed sharply. Revenue jumped from $78.8 million in Q3 2024 to $257.6 million in Q4 2024, the highest in the table, and has stayed between $151.7 million and $257.6 million since. Full-year 2024 EPS came to $9.23, and the first half of 2026 adds up to $15.90. The company beat the EPS estimate in only five of the 15 quarters.

Nutex Health reported Q3 results between November 7 and November 18 in 2022, 2023 and 2024. That points to early or mid-November 2026 for the next report. It will show whether profits stay at the level of the first half.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | $4.95 | $9.38 | 89.34% | $215.0M | $210.8M |
| Q1 2026 | Apr 30, 2026 | $3.99 | $6.52 | 63.27% | $227.8M | $216.5M |
| Q4 2025 | Mar 5, 2026 | $5.56 | $3.11 | -44.03% | $258.8M | $151.7M |
| Q2 2025 | Aug 14, 2025 | −$1.43 | −$2.95 | -105.82% | $244.0M | $244.0M |
| Q1 2025 | May 13, 2025 | $3.04 | $2.56 | -15.88% | $134.2M | $211.8M |
| Q4 2024 | Mar 31, 2025 | −$0.12 | $11.12 | 9118.65% | $81.1M | $257.6M |
| Q3 2024 | Nov 7, 2024 | −$0.24 | −$1.72 | -616.67% | $73.2M | $78.8M |
| Q2 2024 | Aug 8, 2024 | −$0.29 | −$0.07 | 75.86% | $68.2M | $76.1M |
| Q1 2024 | May 9, 2024 | $0.00 | −$0.10 | 0.00% | $64.8M | $67.5M |
| Q4 2023 | Mar 28, 2024 | $0.00 | −$7.50 | 0.00% | $69.7M | $69.7M |
| Q3 2023 | Nov 9, 2023 | −$0.75 | −$1.50 | -100.00% | $63.0M | $62.7M |
| Q2 2023 | Aug 9, 2023 | −$0.75 | −$1.50 | -100.00% | $62.0M | $58.9M |
| Q1 2023 | May 15, 2023 | −$2.25 | −$1.50 | 33.33% | $56.0M | $56.3M |
| Q4 2022 | Mar 2, 2023 | −$2.25 | −$3.00 | -33.33% | $50.0M | $53.7M |
| Q3 2022 | Nov 18, 2022 | $0.00 | −$94.50 | 0.00% | — | $28.4M |

## Frequently Asked Questions

### When did Nutex Health (NUTX) last report earnings?

Nutex Health last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did NUTX beat earnings estimates?

Yes. Nutex Health reported EPS of $9.38 for Q2 2026 against a $4.95 estimate — a 89.34% beat.

### How much revenue did NUTX report last quarter?

Nutex Health reported $210.8M in revenue for Q2 2026, against a consensus estimate of $215.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).